Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03964649 · ClinicalTrials.gov registry record
Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 7,308
- Enrollment target
NCT03964649 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 7,308 participants.
The verdict
NCT03964649 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 7,308 participants
- Enrollment target
Study Summary
To compare rheumatoid arthritis (RA) patient characteristics, adherence, and costs between patients treated with tofacitinib (IR, XR and combined groups) to patients treated with each of the bDMARDs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,308 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2020-04-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03964649
The ClinicalTrials.gov registry entry for NCT03964649 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,308 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03964649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03964649 about?
NCT03964649 is a clinical study titled "Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics". To compare rheumatoid arthritis (RA) patient characteristics, adherence, and costs between patients treated with tofacitinib (IR, XR and combined groups) to patients treated with each of the bDMARDs.
What is the current status of trial NCT03964649?
This trial is currently completed. The enrollment target is 7,308 participants. The study started on 2019-01-01. Estimated completion is 2020-04-06.
Who is sponsoring clinical trial NCT03964649?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.